They work by broadly suppressing immune function in the skin
Results vary depending on your natural skin tone, metabolism, lifestyle habits, and treatment frequency
Excretion Pathways Based on the peptide structure and pharmacokinetic characteristics: Primary elimination likely occurs through hepatic metabolism and biliary excretion Renal excretion of intact peptide appears minimal given the molecular size and protein binding Clearance rates remain consistent across multiple doses, indicating no accumulation beyond steady-state Terminal elimination phase extends several days after the last dose The favorable pharmacokinetic profile, characterized by predictable absorption, limited drug interactions, and steady-state maintenance with weekly dosing, supports the clinical development strategy and dose escalation regimens employed in phase 2 and phase 3 trials
[Multi-Ingredient Formula for Simple Layering] Brings several favorite skincare ingredients together in one bottle, giving you a convenient step that feels complete on its own yet blends smoothly into any routine
Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics
The original Forte is ideal for individuals 40+, focusing on early prevention, while Forte Plus is designed for those 50+ to address more advanced aging signs
